Innovative products to face the key market challenges
Active compounds yield
Low yields burden growers and patients with higher product and manufacturing costs
Substantial variations within varieties produce inconsistent products that have became unreliable as a medical treatment.
Medical tailored products
Specific medical indications require tailored active compounds profile. To date, breeding mainly pushed THC levels.